Preclinical studies have explored its involvement in repair processes, vascular adaptation, and inflammatory regulation, positioning it as a molecule of interest in musculoskeletal and gastrointestinal research contexts (1)
Regulatory and Anti Doping Status BPC157 is not an FDA approved drug product and listed by FDA in 503A Category 2 (bulk drug substances that raise significant safety risks) and on FDAs certain bulk drug substances may present significant safety risks page
Following that notice, compounding BPC-157 for human use became legally restricted in the United States
As detailed in a 2025 review, they create moisture barriers, preserve hydration, regulate pH, control inflammation, and enhance skin functions
Signs of copper excess include nausea, vomiting, abdominal pain, and in severe cases, liver damage